Additionally, Tf-Ost-Lip improved Ost’s therapeutic effects on AD-related pathology in APP/PS-1 mice, which included lowering the deposition of Aβ plaques and preventing oxidative stress, neuroinflammation, and apoptosis. The gene discussed is TF; the disease is Alzheimer disease.